EpCAM, une protéine versatile impliquée dans l’oncogenèse

Olivier Gires

doi:10.1051/medsci/2009255449

Accueil

Tous les numéros

Volume 25 / Numéro 5 (Mai 2009)

Med Sci (Paris), 25 5 (2009) 449-450

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 25, Numéro 5, Mai 2009 Évaluation des risques et perspectives thérapeutiques en oncologie colorectale


Page(s)		449 - 450
Section		Nouvelles
DOI		https://doi.org/10.1051/medsci/2009255449
Publié en ligne		15 mai 2009

Herlyn D, Herlyn M, Steplewski Z, Koprowski H. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Eur J Immunol 1979; 9 : 657–9. [Google Scholar]
Baeuerle PA, Gires O. EpCAM (CD326) finding its role in cancer. Br J Cancer 2007; 96 : 417–23. [Google Scholar]
Balzar M, Briaire-de Bruijn IH, Rees-Bakker HA, et al. Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions. Mol Cell Biol 2001; 21 : 2570–80. [Google Scholar]
Balzar M, Winter MJ, de Boer CJ, Litvinov SV. The biology of the 17-1A antigen (Ep-CAM). J Mol Med 1999; 77 : 699–712. [Google Scholar]
Litvinov SV, Bakker HA, Gourevitch MM, Velders MP, Warnaar SO. Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell 8. adhesion. Cell Adhes Commun 2001; 2 : 417–28. [Google Scholar]
Litvinov SV, Balzar M, Winter MJ, et al. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J Cell Biol 1997; 139 : 1337–48. [Google Scholar]
Osta WA, Chen Y, Mikhitarian K, et al. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 2004; 64 : 5818–24. [Google Scholar]
Munz M, Kieu C, Mack B, et al. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 2004; 23 : 5748–58. [Google Scholar]
Maetzel D, Denzel S, Mack B, et al. Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol 2009; 11 : 162–71. [Google Scholar]
Carpenter G, Red Brewer M. EpCAM: another surface-to-nucleus missile. Cancer Cell 2009; 15 : 165–6. [Google Scholar]
Gires O, Klein CA, Baeuerle PA. On the abundance of EpCAM on cancer stem cells. Nat Rev Cancer 2009; 9 : 143 ; 143. [Google Scholar]
Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8 : 755–68. [Google Scholar]
Kastner P, Chan S. La voie Notch au centre du mécanisme de leucémogenèse dans un modèle murin de leucémies T. Med Sci (Paris) 2006; 22 : 708–10. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Herlyn D, Herlyn M, Steplewski Z, Koprowski H. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Eur J Immunol 1979; 9 : 657–9. [Google Scholar]

[2] Baeuerle PA, Gires O. EpCAM (CD326) finding its role in cancer. Br J Cancer 2007; 96 : 417–23. [Google Scholar]

[3] Balzar M, Briaire-de Bruijn IH, Rees-Bakker HA, et al. Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions. Mol Cell Biol 2001; 21 : 2570–80. [Google Scholar]

[4] Balzar M, Winter MJ, de Boer CJ, Litvinov SV. The biology of the 17-1A antigen (Ep-CAM). J Mol Med 1999; 77 : 699–712. [Google Scholar]

[5] Litvinov SV, Bakker HA, Gourevitch MM, Velders MP, Warnaar SO. Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell 8. adhesion. Cell Adhes Commun 2001; 2 : 417–28. [Google Scholar]

[6] Litvinov SV, Balzar M, Winter MJ, et al. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J Cell Biol 1997; 139 : 1337–48. [Google Scholar]

[7] Osta WA, Chen Y, Mikhitarian K, et al. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 2004; 64 : 5818–24. [Google Scholar]

[8] Munz M, Kieu C, Mack B, et al. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 2004; 23 : 5748–58. [Google Scholar]

[9] Maetzel D, Denzel S, Mack B, et al. Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol 2009; 11 : 162–71. [Google Scholar]

[10] Carpenter G, Red Brewer M. EpCAM: another surface-to-nucleus missile. Cancer Cell 2009; 15 : 165–6. [Google Scholar]

[11] Gires O, Klein CA, Baeuerle PA. On the abundance of EpCAM on cancer stem cells. Nat Rev Cancer 2009; 9 : 143 ; 143. [Google Scholar]

[12] Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8 : 755–68. [Google Scholar]

[13] Kastner P, Chan S. La voie Notch au centre du mécanisme de leucémogenèse dans un modèle murin de leucémies T. Med Sci (Paris) 2006; 22 : 708–10. [Google Scholar]